Inactive Instrument

News Emerald Health Therapeutics

Equities

EMH

CA29102R1064

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

C3 Souvenir Holding, Inc. completed the acquisition of Verdelite Sciences, Inc. from Emerald Health Therapeutics, Inc.	23-02-08	CI
C3 Souvenir Holding, Inc. entered into a share purchase agreement to acquire Verdelite Sciences, Inc. from Emerald Health Therapeutics, Inc. for CAD 12 million.	22-11-13	CI
CSE Bulletin: Delist - Emerald Health Therapeutics, Inc. (EMH)	22-11-11	NE
Skye Bioscience, Inc. completed the acquisition of Emerald Health Therapeutics, Inc. from Emerald Health Sciences Inc. and others.	22-11-09	CI
IIROC Trading Halt - EMH	22-11-09	AQ
Emerald Health Therapeutics Announces Bridge Loan to Skye Bioscience and Provides Update on Merger	22-10-19	AQ
Emerald Health Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-29	CI
Emerald Health Therapeutics Receives Court Approval of Plan of Arrangement with Skye Bioscience	22-08-29	AQ
Skye Bioscience Reports that CSE-listed Emerald Health Therapeutics Shareholders Voted in Favor of Plan of Arrangement	22-08-19	MT
Transcript : Emerald Health Therapeutics, Inc. - Shareholder/Analyst Call	22-08-19
Certain Emerald Health Shareholders Oppose Proposed Merger with Skye Biosciences	22-08-04	MT
Group of Shareholders Oppose Plan of Arrangement Between Emerald Health Therapeutics and Skye Biosciences Inc.	22-08-04	AQ
Emerald Health Therapeutics Announces Revocation of Management Cease Trade Order	22-07-13	AQ
Emerald Health Therapeutics, Inc. Reports 2022 Q1 Results	22-07-12	AQ
Emerald Health Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-07-08	CI
Emerald Health Therapeutics : 2021 Q4	22-07-05	PU
Emerald Health Therapeutics : 2021 - Audited Financial Statements	22-07-05	PU
Emerald Health Therapeutics, Inc. - Reports 2021 Year-end Results and Corporate Update	22-07-05	AQ
Emerald Health Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-06-30	CI
Emerald Health Therapeutics, Inc. Auditor Raises 'Going Concern' Doubt	22-06-29	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Emerald Health Therapeutics

Equities

EMH

CA29102R1064

Summary

Filters